BSF Enterprise PLC (LON:BSFA), the parent to a portfolio of innovative subsidiary companies developing cell-based tissue engineering solutions to deliver sustainable outcomes across a variety of sectors, has provided the following portfolio update.
● Lab Grown Leather (LGL): Revolutionising the leather industry with the world’s first and only scaffold-free lab-grown leather, 3D Bio Tissues (3DBT), on behalf of LGL, is producing leather that is 100% pure animal tissue, cultivated entirely in a lab. Building on the team’s success in producing an animal skin tissue measuring up to 10 by 10 cm in size and over 2 mm in thickness, LGL has now developed a codified ‘Standard Operating Procedure’ that can be transferred, translated and adopted by other companies to develop lab-grown leather. The ‘Standard Operating Procedure’ will be applied to the development of pilot-scale manufacturing operations over the next 12 months. This will enhance scale-up processes as LGL continues to provide samples to support partners and potential partners in the fashion industry.
● Kerato Ltd: Established to provide novel solutions for the treatment of corneal tissue damage, Kerato has developed another commercial product called the LiQD Cornea device.
